Business Context and Reporting Period
Company: Boston Scientific Corporation (BSX)
Filing Type: Form 8-K (Current Report)
Date of Report: February 5, 2025
Reporting Period: Fourth quarter and full year ended December 31, 2024
This filing serves as a notification that the company issued a press release announcing its financial results for the specified period. The detailed financial data is contained in Exhibit 99.1 (Press Release) and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release (Exhibit 99.1) but are not present in the source text provided.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the issuance of results for the fourth quarter and full year 2024.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risks, contingencies, or unusual items. These elements are expected to be detailed in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, earnings per share, and cash flow figures for Q4 and Full Year 2024.
- Verify year-over-year growth rates and margin performance in the attached press release.
- Check for any updated 2025 financial guidance or outlook provided in the press release.
- Confirm the status of the 0.625% Senior Notes due 2027 (BSX27) listed as registered securities.